• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亨廷顿舞蹈症突变的全球研究。测量CAG重复序列的敏感性和特异性。

A worldwide study of the Huntington's disease mutation. The sensitivity and specificity of measuring CAG repeats.

作者信息

Kremer B, Goldberg P, Andrew S E, Theilmann J, Telenius H, Zeisler J, Squitieri F, Lin B, Bassett A, Almqvist E

机构信息

Department of Medical Genetics, University of British Columbia, Vancouver, Canada.

出版信息

N Engl J Med. 1994 May 19;330(20):1401-6. doi: 10.1056/NEJM199405193302001.

DOI:10.1056/NEJM199405193302001
PMID:8159192
Abstract

BACKGROUND

Huntington's disease is associated with an expanded sequence of CAG repeats in a gene on chromosome 4p16.3. However, neither the sensitivity of expanded CAG repeats in affected persons of different ethnic origins nor the specificity of such repeats for Huntington's disease as compared with other neuropsychiatric disorders has been determined.

METHODS

We studied 1007 patients with diagnosed Huntington's disease from 565 families and 43 national and ethnic groups. In addition, the length of the CAG repeat was determined in 113 control subjects with a family history of Alzheimer's disease (44 patients), schizophrenia (39), major depression (16), senile chorea (5), benign hereditary chorea (5), neuroacanthocytosis (2), and dentatorubropallidoluysian atrophy (2). The number of CAG repeats was also assessed in 1595 control chromosomes, with the size of adjacent polymorphic CCG trinucleotide repeats taken into account.

RESULTS

Of 1007 patients with signs and symptoms compatible with a diagnosis of Huntington's disease, 995 had an expanded CAG repeat that included from 36 to 121 repeats (median, 44) (sensitivity, 98.8 percent; 95 percent confidence interval, 97.7 to 99.4 percent). There were no significant differences among national and ethnic groups in the number of repeats. No CAG expansion was found in the 110 control subjects with other neuropsychiatric disorders (specificity, 100 percent; 95 percent confidence interval, 95.2 to 100 percent). In 1581 of the 1595 control chromosomes (99.1 percent), the number of CAG repeats ranged from 10 to 29 (median, 18). In 12 control chromosomes (0.75 percent), intermediate-sized CAG sequences with 30 to 35 repeats were found, and 2 normal chromosomes unexpectedly had expanded CAG sequences, of 39 and 37 repeats.

CONCLUSIONS

CAG trinucleotide expansion is the molecular basis of Huntington's disease worldwide and is a highly sensitive and specific marker for inheritance of the disease mutation.

摘要

背景

亨廷顿舞蹈症与4号染色体p16.3区域一个基因中CAG重复序列的扩增有关。然而,不同种族的亨廷顿舞蹈症患者中CAG重复序列扩增的敏感性,以及与其他神经精神疾病相比,此类重复序列对亨廷顿舞蹈症的特异性均未得到确定。

方法

我们研究了来自565个家庭、43个民族的1007例确诊为亨廷顿舞蹈症的患者。此外,还测定了113名有阿尔茨海默病家族史(44例患者)、精神分裂症家族史(39例)、重度抑郁症家族史(16例)、老年舞蹈症家族史(5例)、良性遗传性舞蹈症家族史(5例)、神经棘红细胞增多症家族史(2例)以及齿状核红核苍白球路易体萎缩家族史(2例)的对照受试者的CAG重复序列长度。同时,在考虑相邻多态性CCG三核苷酸重复序列大小的情况下,对1595条对照染色体中的CAG重复序列数量进行了评估。

结果

在1007例有符合亨廷顿舞蹈症诊断的体征和症状的患者中,995例有CAG重复序列扩增,重复次数在36至121次之间(中位数为44次)(敏感性为98.8%;95%置信区间为97.7%至99.4%)。不同民族之间的重复次数无显著差异。在110例患有其他神经精神疾病的对照受试者中未发现CAG扩增(特异性为100%;95%置信区间为95.2%至100%)。在1595条对照染色体中的1581条(99.1%)中,CAG重复序列数量在10至29次之间(中位数为18次)。在12条对照染色体(0.75%)中,发现了重复次数为30至35次的中等大小CAG序列,另外有2条正常染色体意外出现了CAG序列扩增,重复次数分别为39次和37次。

结论

CAG三核苷酸扩增是全球范围内亨廷顿舞蹈症的分子基础,是该疾病突变遗传的高度敏感和特异的标志物。

相似文献

1
A worldwide study of the Huntington's disease mutation. The sensitivity and specificity of measuring CAG repeats.亨廷顿舞蹈症突变的全球研究。测量CAG重复序列的敏感性和特异性。
N Engl J Med. 1994 May 19;330(20):1401-6. doi: 10.1056/NEJM199405193302001.
2
[Importance of the number of trinucleotide repeat expansions in the clinical manifestations of Huntington's chorea].[三核苷酸重复扩增数目在亨廷顿舞蹈病临床表现中的重要性]
Srp Arh Celok Lek. 1998 Mar-Apr;126(3-4):77-82.
3
[Molecular genetics of Huntington's disease].[亨廷顿舞蹈症的分子遗传学]
Rinsho Shinkeigaku. 1995 Dec;35(12):1529-31.
4
[Analysis of trinucleotide repeat expansion as a new mechanism of mutation in Huntington's chorea: theoretical and applied aspects].[三核苷酸重复序列扩增作为亨廷顿舞蹈症新突变机制的分析:理论与应用方面]
Genetika. 1996 Jan;32(1):103-9.
5
Molecular analysis of the Huntington's disease gene in New Zealand.新西兰亨廷顿舞蹈症基因的分子分析。
N Z Med J. 1996 Feb 9;109(1015):27-30.
6
[Huntington chorea: (CAG)n repeats on gene IT 15 in Austria].[亨廷顿舞蹈症:奥地利人群中IT 15基因上的(CAG)n重复序列]
Wien Klin Wochenschr. 1994;106(21):671-2.
7
[The gene responsible for Huntington's disease in Spanish families: its diagnostic value and the relation between trinucleotide expansion and the clinical characteristics].[西班牙家族中亨廷顿舞蹈症的致病基因:其诊断价值以及三核苷酸重复序列扩增与临床特征的关系]
Rev Clin Esp. 1994 Aug;194(8):591-3.
8
Trinucleotide repeat length and rate of progression of Huntington's disease.亨廷顿舞蹈症的三核苷酸重复序列长度与疾病进展速率
Ann Neurol. 1994 Oct;36(4):630-5. doi: 10.1002/ana.410360412.
9
DNA haplotype analysis of CAG repeat in Taiwanese Huntington's disease patients.台湾亨廷顿舞蹈症患者CAG重复序列的DNA单倍型分析。
Eur Neurol. 2004;52(2):96-100. doi: 10.1159/000079938. Epub 2004 Jul 22.
10
De novo expansion of a (CAG)n repeat in sporadic Huntington's disease.散发性亨廷顿舞蹈病中(CAG)n重复序列的从头扩增
Nat Genet. 1993 Oct;5(2):168-73. doi: 10.1038/ng1093-168.

引用本文的文献

1
Innate Immune Mechanisms in the Central Nervous System.中枢神经系统中的固有免疫机制
Adv Exp Med Biol. 2025;1476:381-409. doi: 10.1007/978-3-031-85340-1_15.
2
Durable silencing using non-evolved dCas9 epigenome editors in patient-derived cells.在患者来源的细胞中使用未进化的dCas9表观基因组编辑器实现持久沉默。
Mol Ther Nucleic Acids. 2025 May 14;36(2):102561. doi: 10.1016/j.omtn.2025.102561. eCollection 2025 Jun 10.
3
Glutamine missense suppressor transfer RNAs inhibit polyglutamine aggregation.谷氨酰胺错义抑制性转运核糖核酸抑制多聚谷氨酰胺聚集。
Mol Ther Nucleic Acids. 2024 Dec 21;36(1):102442. doi: 10.1016/j.omtn.2024.102442. eCollection 2025 Mar 11.
4
Serum neurofilament light chain but not serum glial fibrillary acidic protein is a marker of early Huntington's disease.血清神经丝轻链而非血清胶质纤维酸性蛋白是早期亨廷顿病的一个标志物。
J Neurol. 2025 Feb 1;272(2):174. doi: 10.1007/s00415-025-12901-y.
5
Rural Environment as a Risk Factor for the Age at Onset of Machado-Joseph Disease.农村环境作为马查多-约瑟夫病发病年龄的一个风险因素。
Mov Disord Clin Pract. 2025 Apr;12(4):520-526. doi: 10.1002/mdc3.14338. Epub 2025 Jan 20.
6
G9a an Epigenetic Therapeutic Strategy for Neurodegenerative Conditions: From Target Discovery to Clinical Trials.G9a:神经退行性疾病的一种表观遗传治疗策略——从靶点发现到临床试验
Med Res Rev. 2025 May;45(3):985-1015. doi: 10.1002/med.22096. Epub 2025 Jan 6.
7
No Evidence of Early Developmental Delay in Juvenile-Onset Huntington's Disease Patients.青少年型亨廷顿舞蹈症患者无早期发育迟缓迹象。
Mov Disord Clin Pract. 2025 Mar;12(3):346-352. doi: 10.1002/mdc3.14287. Epub 2024 Dec 7.
8
Developmental and physiological impacts of pathogenic human huntingtin protein in the nervous system.致病性人类亨廷顿蛋白在神经系统中的发育和生理影响。
Neurobiol Dis. 2024 Dec;203:106732. doi: 10.1016/j.nbd.2024.106732. Epub 2024 Nov 12.
9
Medication Use and Treatment Indications in Huntington's Disease; Analyses from a Large Cohort.亨廷顿舞蹈症的药物使用与治疗指征;来自一个大型队列的分析
Mov Disord Clin Pract. 2024 Dec;11(12):1530-1541. doi: 10.1002/mdc3.14230. Epub 2024 Oct 21.
10
Pediatric Huntington Disease Brains Have Distinct Morphologic and Metabolic Traits: the RAREST-JHD Study.小儿亨廷顿舞蹈病大脑具有独特的形态学和代谢特征:RAREST-JHD研究
Mov Disord Clin Pract. 2024 Dec;11(12):1592-1597. doi: 10.1002/mdc3.14223. Epub 2024 Oct 5.